Quarterly report pursuant to Section 13 or 15(d)

Revision to Prior Period Financial Statements (Tables)

v3.21.1
Revision to Prior Period Financial Statements (Tables)
3 Months Ended
Mar. 31, 2021
Revision to Prior Period Financial Statements  
Summarize the effect of the revision to the Post-IPO Balance Sheet

​

​

​

​

​

​

​

​

​

​

​

​

    

As of February 2, 2021

​

​

As Previously

​

Revised

​

  

​

​

    

Reported

    

Adjustment

    

As Revised

​

​

​

​

​

​

​

​

​

​

Balance Sheet

 

​

  

 

​

  

 

​

  

Total assets

​

$

289,785,365

​

$

—

​

$

289,785,365

Liabilities, redeemable non-controlling interest and shareholders’ equity

​

 

  

​

 

  

​

 

  

Total current liabilities

​

$

642,351

​

$

—

​

$

642,351

Deferred underwriting commissions

​

 

10,062,500

​

 

—

​

 

10,062,500

Derivative warrant liabilities

​

 

—

​

 

10,638,000

​

 

10,638,000

Total liabilities

​

 

10,704,851

​

 

10,638,000

​

 

21,342,851

Class A ordinary shares, $0.0001 par value; shares subject to possible redemption

​

 

274,080,510

​

 

(10,638,000)

​

 

263,442,510

Shareholders’ equity

​

 

  

​

 

  

​

 

  

Preference shares - $0.0001 par value

​

 

—

​

 

—

​

 

—

Class A ordinary shares - $0.0001 par value

​

 

214

​

 

107

​

 

321

Class B ordinary shares - $0.0001 par value

​

 

719

​

 

—

​

 

719

Additional paid-in-capital

​

 

5,030,402

​

 

590,767

​

 

5,621,169

Accumulated deficit

​

 

(31,331)

​

 

(590,874)

​

 

(622,205)

Total shareholders’ equity

​

 

5,000,004

​

 

—

​

 

5,000,004

Total liabilities and shareholders’ equity

​

$

289,785,365

​

$

—

​

$

289,785,365